Fredun Pharmaceuticals share news and announcements
NSE: FREDUNBSE: 539730Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹1,391.00.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹2,313 Cr1,474th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 29 May 2026
- 8.3
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.02%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 5 Aug 2026
- 18.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 29 May 2026
- 0.80
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 52,74940.2% delivered
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Fredun Pharmaceuticals quarterly results
The board met on 5 Aug 2026 to consider quarterly results
Notice filed 30 Jul 2026
Fredun Pharmaceuticals annual reports, presentations and earnings calls
The company's own documents, latest first.Fredun Pharmaceuticals financials, year by year
Annual reports26
- Annual report, year to Mar 2026 (opens in a new tab)8 Jun 2026
- Annual report, year to Mar 2025 (opens in a new tab)8 Sep 2025
- Annual report, year to Mar 2024 (opens in a new tab)6 Sep 2024
- Annual report, year to Mar 2023 (opens in a new tab)25 Sep 2023
- Annual report, year to Mar 2022 (opens in a new tab)8 Sep 2022
21 earlier reports
- Annual report, year to Mar 2021 (opens in a new tab)4 Sep 2021
- Annual report, year to Mar 2020 (opens in a new tab)5 Sep 2020
- Annual report, year to Mar 2019 (opens in a new tab)31 Aug 2019
- Annual report, year to Mar 2018 (opens in a new tab)27 Sep 2018
- Annual report, year to Mar 2017 (opens in a new tab)1 Nov 2017
- Annual report, year to Mar 2016 (opens in a new tab)30 Sep 2016
- Annual report, year to Mar 2015 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2014 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2013 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2012 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2010 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2009 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2008 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2007 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2006 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2005 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2004 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2003 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2002 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2001 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2000 (opens in a new tab)Filing day not known
Investor presentations3
- INVESTOR PRESENTATION OF FREDUN PHARMACEUTICALS LIMITED (opens in a new tab)10 Jun 2025
- We are enclosing herewith the Investor Presentation. (opens in a new tab)21 Feb 2023
- Please find enclosed herewith the Corporate Presentation of the Company for the shareholders perusal. (opens in a new tab)15 Jun 2019
Earnings calls11
- Transcript of the Earnings Conference call held on 13th August, 2026 for Q1 FY27. (opens in a new tab)17 Aug 2026
- Audio Recording Q1 FY27 'Earnings Conference Call' of Fredun Pharmaceuticals Limited. (opens in a new tab)13 Aug 2026
- Transcript of the Earnings conference call held on 10th June 2026 for Q4 FY26. (opens in a new tab)12 Jun 2026
- Audio Recording of the Q4 and year ended for the FY26 'Earnings Conference Call' (opens in a new tab)10 Jun 2026
- Intimation of Earning Conference call for the quarter Q4 of FY 2026. (opens in a new tab)6 Jun 2026
6 earlier call documents
- Transcript of Earnings Call held on 12th February, 2026 for Q3 and 9 months FY 2026. (opens in a new tab)17 Feb 2026
- Transcript of the Earnings Conference call held on 11th November 2025 for Q2 & H1 FY26. (opens in a new tab)14 Nov 2025
- Website Link of Audio Recording of the Q2 FY26 "Earnings Conference Call" (opens in a new tab)12 Nov 2025
- TRANSCRIPT OF THE EARNINGS CONFERENCE CALL HELD ON 1ST AUGUST 2025 FOR Q1 FY26 RESULTS. (opens in a new tab)6 Aug 2025
- Audio Recording of the Q1 FY26 "Earnings Conference Call" (opens in a new tab)1 Aug 2025
- Audio Recording of the Q1 FY25 "Earnings Conference Call" (opens in a new tab)1 Aug 2025
Fredun Pharmaceuticals share news and announcements
663 announcements, routine notices left out, newest first. Page 1 of 14.
Oct 2026
23 Oct · Announcement under Regulation 30 (LODR)-Allotment
5 Oct · Announcement under Regulation 30 (LODR)-Allotment
5 Oct · Board meeting
3 Oct · Announcement under Regulation 30 (LODR)-Allotment
Sep 2026
22 Sep · Announcement under Regulation 30 (LODR)-Allotment
22 Sep · Board meeting
22 Sep · Business
16 Sep · Board meeting
Meeting on 16 Sep 202616 Sep · Announcement under Regulation 30 (LODR)-Allotment
15 Sep · Business
15 Sep · Business
Aug 2026
17 Aug · Intimation Regarding Permission To Trade And Admission Of Equity Shares To Dealings On The National Stock Exchange Of India Limited.
14 Aug · Business
5 Aug · Results
Jul 2026
30 Jul · Board meeting
Meeting on 5 Aug 2026: quarterly results17 Jul · Announcement under Regulation 30 (LODR)-Allotment
Jun 2026
30 Jun · Meeting
8 Jun · Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations").
May 2026
15 May · Board meeting
Meeting on 25 May 2026: bonus issue, final dividend and audited results
Apr 2026
How the price met the news
The latest 30. The first session after each announcement, beside the market. Moves to 9 Jun 2026 are on BSE closes, before the company traded on NSE.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.
- 9 Jun 2026Dividendup 0.59%−0.3 pts vs Nifty 500market median 0.0% · five sessions +0.7% (−2.5 pts vs Nifty 500) · volume 0.5× usual · The announcement (opens in a new tab)
- 26 May 2026Board or managers changedup 0.57%+0.7 pts vs Nifty 500market median 0.0% · five sessions −0.4% (+1.4 pts vs Nifty 500) · volume 1.2× usual · The announcement (opens in a new tab)
- 17 Feb 2026Board or managers changedup 1.29%+1.0 pts vs Nifty 500market median 0.0% · five sessions −4.5% (−4.5 pts vs Nifty 500) · volume 0.6× usual · The announcement (opens in a new tab)
- 1 Dec 2025Board or managers changedup 0.80%+0.8 pts vs Nifty 500market median 0.0% · five sessions −2.6% (−2.2 pts vs Nifty 500) · volume 0.5× usual · The announcement (opens in a new tab)
- 10 Nov 2025Board or managers changedup 5.00%+4.7 pts vs Nifty 500market median 0.0% · five sessions +15.3% (+13.9 pts vs Nifty 500) · volume 1.0× usual · The announcement (opens in a new tab)
- 7 Oct 2025Board or managers changedup 2.09%+1.9 pts vs Nifty 500market median 0.0% · five sessions +6.7% (+6.1 pts vs Nifty 500) · volume 0.4× usual · The announcement (opens in a new tab)
- 1 Oct 2025Board or managers changedup 1.11%+0.3 pts vs Nifty 500market median 0.0% · five sessions +8.3% (+6.6 pts vs Nifty 500) · volume 0.5× usual · The announcement (opens in a new tab)
- 9 Sep 2025Dividenddown 3.52%−3.8 pts vs Nifty 500market median 0.0% · five sessions −9.1% (−10.6 pts vs Nifty 500) · volume 0.3× usual · The announcement (opens in a new tab)
- 31 Jul 2025Board or managers changedup 3.40%+3.9 pts vs Nifty 500market median 0.0% · five sessions +14.9% (+16.5 pts vs Nifty 500) · volume 2.5× usual · The announcement (opens in a new tab)
- 11 Jul 2025Order receivedup 1.89%+2.7 pts vs Nifty 500market median +1.1% · five sessions +11.9% (+12.1 pts vs Nifty 500) · volume 1.2× usual · The announcement (opens in a new tab)
20 earlier announcements
- 2 Jun 2025Board or managers changeddown 7.71%−7.9 pts vs Nifty 500market median 0.0% · five sessions −5.5% (−7.1 pts vs Nifty 500) · volume 4.7× usual · The announcement (opens in a new tab)
- 19 May 2025Board or managers changedup 2.35%+2.4 pts vs Nifty 500market median 0.0% · five sessions +6.4% (+6.8 pts vs Nifty 500) · volume 0.8× usual · The announcement (opens in a new tab)
- 25 Feb 2025Board or managers changedup 0.79%+1.0 pts vs Nifty 500market median 0.0% · five sessions −2.8% (−0.1 pts vs Nifty 500) · volume 0.7× usual · The announcement (opens in a new tab)
- 19 Feb 2025Board or managers changedup 4.83%+4.3 pts vs Nifty 500market median 0.0% · five sessions +5.6% (+6.5 pts vs Nifty 500) · volume 0.4× usual · The announcement (opens in a new tab)
- 9 Sep 2024Dividenddown 0.96%−1.1 pts vs Nifty 500market median 0.0% · five sessions −0.6% (−2.5 pts vs Nifty 500) · volume 0.6× usual · The announcement (opens in a new tab)
- 13 May 2024Dividenddown 4.86%−5.1 pts vs Nifty 500market median 0.0% · five sessions +1.9% (−1.0 pts vs Nifty 500) · volume 0.7× usual · The announcement (opens in a new tab)
- 8 May 2024Dividenddown 9.69%−10.0 pts vs Nifty 500market median 0.0% · five sessions −14.9% (−15.1 pts vs Nifty 500) · volume 2.1× usual · The announcement (opens in a new tab)
- 22 Dec 2023Board or managers changedup 1.26%+0.7 pts vs Nifty 500market median 0.0% · five sessions −0.4% (−3.0 pts vs Nifty 500) · volume 0.7× usual · The announcement (opens in a new tab)
- 28 Nov 2023Board or managers changedup 3.62%+3.1 pts vs Nifty 500market median 0.0% · five sessions −0.8% (−5.3 pts vs Nifty 500) · volume 2.0× usual · The announcement (opens in a new tab)
- 9 Nov 2023Board or managers changeddown 3.23%−3.0 pts vs Nifty 500market median 0.0% · five sessions −2.9% (−4.3 pts vs Nifty 500) · volume 2.8× usual · The announcement (opens in a new tab)
- 7 Sep 2023Dividenddown 3.61%−4.2 pts vs Nifty 500market median 0.0% · five sessions −8.3% (−9.7 pts vs Nifty 500) · volume 2.4× usual · The announcement (opens in a new tab)
- 20 Jul 2023Board or managers changeddown 0.37%−0.9 pts vs Nifty 500market median 0.0% · five sessions +24.5% (+24.3 pts vs Nifty 500) · volume 0.9× usual · The announcement (opens in a new tab)
- 26 May 2023Dividendup 0.02%−0.9 pts vs Nifty 500market median 0.0% · five sessions −2.3% (−3.6 pts vs Nifty 500) · volume 5.0× usual · The announcement (opens in a new tab)
- 26 May 2023Board or managers changedup 0.02%−0.9 pts vs Nifty 500market median 0.0% · five sessions −2.3% (−3.6 pts vs Nifty 500) · volume 5.0× usual · The announcement (opens in a new tab)
- 25 May 2023Dividenddown 5.37%−5.6 pts vs Nifty 500market median 0.0% · five sessions −8.6% (−10.3 pts vs Nifty 500) · volume 3.1× usual · The announcement (opens in a new tab)
- 22 May 2023Dividenddown 0.81%−1.4 pts vs Nifty 500market median 0.0% · five sessions −3.5% (−5.3 pts vs Nifty 500) · volume 0.7× usual · The announcement (opens in a new tab)
- 9 Sep 2022Dividenddown 0.05%−0.2 pts vs Nifty 500market median 0.0% · five sessions −2.5% (−3.4 pts vs Nifty 500) · volume 0.3× usual · The announcement (opens in a new tab)
- 17 May 2022Dividendup 5.00%+2.4 pts vs Nifty 500market median 0.0% · five sessions −4.4% (−6.3 pts vs Nifty 500) · volume 0.6× usual · The announcement (opens in a new tab)
- 9 May 2022Dividendup 1.60%+2.7 pts vs Nifty 500market median 0.0% · five sessions −9.3% (−4.5 pts vs Nifty 500) · volume 1.4× usual · The announcement (opens in a new tab)
- 21 Oct 2021Board or managers changeddown 0.92%−0.4 pts vs Nifty 500market median 0.0% · five sessions +1.1% (+1.7 pts vs Nifty 500) · volume 0.3× usual · The announcement (opens in a new tab)
Figures filed again
Lines the company later filed with a different value, rupee lines in ₹ crore and per-share lines in rupees.
| Line | Period | Accounts | First filed | Filed again | Change. The value filed again less the value first filed, as a per cent of the first. | First filed on | Filed again on |
|---|---|---|---|---|---|---|---|
| Tax | Year to date to Mar 2026 | Consolidated | 111.33 | 14.38 | −87.1% | 25 May 2026 (opens in a new tab) | 29 May 2026 (opens in a new tab) |
| Tax | Year to Mar 2026 | Consolidated | 111.33 | 14.38 | −87.1% | 25 May 2026 (opens in a new tab) | 29 May 2026 (opens in a new tab) |
| Net profit | Year to date to Mar 2026 | Consolidated | −64.33 | 32.62 | +150.7% | 25 May 2026 (opens in a new tab) | 29 May 2026 (opens in a new tab) |
| Net profit | Year to Mar 2026 | Consolidated | −64.33 | 32.62 | +150.7% | 25 May 2026 (opens in a new tab) | 29 May 2026 (opens in a new tab) |
| Net profit from continuing businesses | Year to date to Mar 2026 | Consolidated | −64.33 | 32.62 | +150.7% | 25 May 2026 (opens in a new tab) | 29 May 2026 (opens in a new tab) |
| Net profit from continuing businesses | Year to Mar 2026 | Consolidated | −64.33 | 32.62 | +150.7% | 25 May 2026 (opens in a new tab) | 29 May 2026 (opens in a new tab) |
| Total comprehensive income | Year to date to Mar 2026 | Consolidated | −64.16 | 32.79 | +151.1% | 25 May 2026 (opens in a new tab) | 29 May 2026 (opens in a new tab) |
| Total comprehensive income | Year to Mar 2026 | Consolidated | −64.16 | 32.79 | +151.1% | 25 May 2026 (opens in a new tab) | 29 May 2026 (opens in a new tab) |